Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs LLLT for Impacted Third Molar Surgery
NCT06836570Completed
- Sponsor
- Van Yuzuncu Yil University
- Start
- May 2022
- Primary completion
- Apr 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised trial of autologous platelet-rich plasma in impacted third molar (I3M) (2 arms), sponsored by Van Yuzuncu Yil University. Primary endpoints: Visual Analog Scale at 7 days, Maximum Mouth Opening at 7 days and 1 more. Started May 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT06836570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836570.